Key Insights

Highlights

Success Rate

85% trial completion

Published Results

28 trials with published results (30%)

Research Maturity

58 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

10.6%

10 terminated out of 94 trials

Success Rate

85.3%

-1.2% vs benchmark

Late-Stage Pipeline

38%

36 trials in Phase 3/4

Results Transparency

48%

28 of 58 completed with results

Key Signals

28 with results85% success

Data Visualizations

Phase Distribution

73Total
Not Applicable (17)
P 1 (4)
P 2 (16)
P 3 (18)
P 4 (18)

Trial Status

Completed58
Recruiting13
Terminated10
Unknown4
Not Yet Recruiting3
Active Not Recruiting3

Trial Success Rate

85.3%

Benchmark: 86.5%

Based on 58 completed trials

Clinical Trials (94)

Showing 20 of 20 trials
NCT06724991Not ApplicableEnrolling By InvitationPrimary

Lower vs. Standard Insulin-Dextrose Doses for Treating Mild to Moderate Hyperkalemia in the Emergency Department

NCT07523867Phase 4Not Yet Recruiting

Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study

NCT07494266Not ApplicableNot Yet RecruitingPrimary

Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited Potassium Content in Patients With Chronic Kidney Disease: A Pilot Study

NCT05004363Phase 3Completed

Lokelma for RAAS Maximisation in CKD & Heart Failure.

NCT07370194RecruitingPrimary

Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil

NCT05136664Phase 3CompletedPrimary

Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects

NCT07054905CompletedPrimary

Prediction of Hyperkalemia in Dialysis Patients Through Waveform Analysis Using Wearable ECG

NCT05766839Phase 2RecruitingPrimary

Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age

NCT06884267Not ApplicableRecruitingPrimary

Hyperkalemia Quality Improvement Program (HK-QIP) Study

NCT06366230Phase 1Recruiting

Adding Urea to the Final Dialysis Fluid

NCT03253172Not ApplicableActive Not Recruiting

Potassium Supplementation in CKD

NCT05090865Not ApplicableRecruiting

Dietary Potassium Liberalization in Pre-Dialysis Patients

NCT05056727Phase 3Terminated

A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

NCT04510792WithdrawnPrimary

IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors

NCT06036823Phase 4CompletedPrimary

5 Versus 10 Units of Insulin in Hyperkalemia Management

NCT06256991Phase 4Recruiting

Potassium Correction for RAAS Optimization in Chronic Kidney Disease

NCT07277530Not ApplicableCompleted

Nurse-Led Nutritional Education for Moroccan Dialysis Patients

NCT07251309Phase 3RecruitingPrimary

A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia

NCT07210021RecruitingPrimary

AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring

NCT05297409CompletedPrimary

An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure

Scroll to load more

Research Network

Activity Timeline